CAR-T Cell Therapy for Acute Lymphoblastic Leukemia: Transforming the Treatment of Relapsed and Refractory Disease

被引:0
作者
Katherine C. Pehlivan
Brynn B. Duncan
Daniel W. Lee
机构
[1] University of Virginia,Division of Pediatric Hematology/Oncology, Department of Pediatrics
[2] University of Virginia,Department of Pediatrics
[3] University of Virginia,Division of Pediatric Hematology/Oncology, Department of Pediatrics, Department of Internal Medicine
来源
Current Hematologic Malignancy Reports | 2018年 / 13卷
关键词
Chimeric antigen receptor; Immunotherapy; Acute lymphoblastic leukemia; CNS leukemia; Cytokine release syndrome; Neurotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:396 / 406
页数:10
相关论文
共 510 条
[1]  
Rosenbaum L(2017)Tragedy, perseverance, and chance—the story of CAR-T therapy N Engl J Med 377 1313-1315
[2]  
Ward E(2014)Childhood and adolescent cancer statistics, 2014 CA Cancer J Clin 64 83-103
[3]  
DeSantis C(2013)Relapsed childhood acute lymphoblastic leukaemia Lancet Oncol 14 e217-2816
[4]  
Robbins A(2012)How I treat relapsed childhood acute lymphoblastic leukemia Blood 120 2807-950
[5]  
Kohler B(2014)Survival of adults with acute lymphoblastic leukemia in Germany and the United States PLoS One 9 944-1517
[6]  
Jemal A(2007)Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study Blood 109 224ra25-528
[7]  
Bhojwani D(2014)Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia Sci Translat Med 6 1507-2001
[8]  
Pui C-H(2014)Chimeric antigen receptor T cells for sustained remissions in leukemia New England J Med 371 517-11004
[9]  
Locatelli F(2015)T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial Lancet 385 2123-1464
[10]  
Schrappe M(2016)CD19 CAR–T cells of defined CD4 : CD8 composition in adult B cell ALL patients J Clin Investig 126 1999-3365